Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.

PURPOSE Parotid-sparing head-and-neck intensity-modulated radiotherapy (IMRT) can reduce long-term xerostomia. However, patients frequently experience weight loss and tumor shrinkage during treatment. We evaluate the use of kilovoltage (kV) cone beam computed tomography (CBCT) for dose monitoring and examine if the dosimetric impact of such changes on the parotid and critical neural structures warrants replanning during treatment. METHODS AND MATERIALS Ten patients with locally advanced oropharyngeal cancer were treated with contralateral parotid-sparing IMRT concurrently with platinum-based chemotherapy. Mean doses of 65 Gy and 54 Gy were delivered to clinical target volume (CTV)1 and CTV2, respectively, in 30 daily fractions. CBCT was prospectively acquired weekly. Each CBCT was coregistered with the planned isocenter. The spinal cord, brainstem, parotids, larynx, and oral cavity were outlined on each CBCT. Dose distributions were recalculated on the CBCT after correcting the gray scale to provide accurate Hounsfield calibration, using the original IMRT plan configuration. RESULTS Planned contralateral parotid mean doses were not significantly different to those delivered during treatment (p > 0.1). Ipsilateral and contralateral parotids showed a mean reduction in volume of 29.7% and 28.4%, respectively. There was no significant difference between planned and delivered maximum dose to the brainstem (p = 0.6) or spinal cord (p = 0.2), mean dose to larynx (p = 0.5) and oral cavity (p = 0.8). End-of-treatment mean weight loss was 7.5 kg (8.8% of baseline weight). Despite a ≥10% weight loss in 5 patients, there was no significant dosimetric change affecting the contralateral parotid and neural structures. CONCLUSIONS Although patient weight loss and parotid volume shrinkage was observed, overall, there was no significant excess dose to the organs at risk. No replanning was felt necessary for this patient cohort, but a larger patient sample will be investigated to further confirm these results. Nevertheless, kilovoltage CBCT is a valuable tool for patient setup verification and monitoring of dosimetric variation during radiotherapy.

[1]  L. Dawson,et al.  Changes in Position and Size of Parotid Glands Assessed With Daily Cone-Beam CT During Image-Guided IMRT for Head and Neck Cancer: Implications for Dose Received , 2007 .

[2]  Radhe Mohan,et al.  Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? , 2007, International journal of radiation oncology, biology, physics.

[3]  D. Dearnaley,et al.  Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  D. Jaffray,et al.  The influence of antiscatter grids on soft-tissue detectability in cone-beam computed tomography with flat-panel detectors. , 2004, Medical physics.

[5]  S Webb,et al.  An efficient Monte Carlo-based algorithm for scatter correction in keV cone-beam CT , 2009, Physics in medicine and biology.

[6]  D. Hallahan,et al.  A study on adaptive IMRT treatment planning using kV cone-beam CT. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Ben Heijmen,et al.  Correction of conebeam CT values using a planning CT for derivation of the "dose of the day". , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  T. Marchant,et al.  Shading correction algorithm for improvement of cone-beam CT images in radiotherapy , 2008, Physics in medicine and biology.

[9]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  M. Yewondwossen,et al.  Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[11]  Jeng-Fong Chiou,et al.  Effect of Regression of Enlarged Neck Lymph Nodes on Radiation Doses Received by Parotid Glands During Intensity-Modulated Radiotherapy for Head and Neck Cancer , 2006, American journal of clinical oncology.

[12]  Ping Xia,et al.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[13]  M. Hoogeman,et al.  Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. , 2008, International journal of radiation oncology, biology, physics.

[14]  L. Verhey,et al.  Immobilizing and Positioning Patients for Radiotherapy. , 1995, Seminars in radiation oncology.

[15]  Radhe Mohan,et al.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. , 2004, International journal of radiation oncology, biology, physics.

[16]  SU-FF-T-163: Dose Calculation On Cone Beam CT (CBCT) , 2007 .

[17]  S. Richard,et al.  A simple, direct method for x-ray scatter estimation and correction in digital radiography and cone-beam CT. , 2005, Medical physics.